- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04954976
Orthodontic Retention In France - ORIF (ORIF)
July 7, 2021 updated by: Nantes University Hospital
Epidemiologic Study of Orthodontic Retention Practices in France
The goal of this study is to survey retention procedures used by French orthodontists, and evaluate the needs for practice guidelines.
The hypothesis is that there is no consensus among orthodontists, requiring practice homogenization via expert guidelines.
Similar studies have been driven in others European countries (such as Swiss, the Netherlands, Lithuania and Norway), but not in France.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Questionnaire aggregating 27 questions on orthodontic retention strategies, was sent to a professional list of French orthodontists from health authorities.
The survey was composed of eight parts, about sociodemographic status, retention system selection, choice of fixed and removable retention system, retention period, supervision, given instruction and needs for practice guidelines.
Study Type
Observational
Enrollment (Actual)
262
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Loire-Atlantique
-
Nantes, Loire-Atlantique, France, 44093
- Nantes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
French orthodontists
Description
Inclusion Criteria:
- All French Specialist orthodontists trained in France who answer the survey
Exclusion Criteria:
- Non-specialist orthodontists, not trained in France
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of technics
Time Frame: Day0 = Response to the Suvey
|
Retention system selection, choice of fixed and removable retention system, retention period, supervision, given instruction and needs for practice guidelines.
|
Day0 = Response to the Suvey
|
|
Description of materials
Time Frame: Day0 = Response to the Suvey
|
Retention system selection, choice of fixed and removable retention system, retention period, supervision, given instruction and needs for practice guidelines.
|
Day0 = Response to the Suvey
|
|
Description of retention strategies used by clinicians.
Time Frame: Day0 = Response to the Suvey
|
Retention system selection, choice of fixed and removable retention system, retention period, supervision, given instruction and needs for practice guidelines.
|
Day0 = Response to the Suvey
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2021
Primary Completion (Actual)
February 2, 2021
Study Completion (Actual)
February 2, 2021
Study Registration Dates
First Submitted
June 16, 2021
First Submitted That Met QC Criteria
July 7, 2021
First Posted (Actual)
July 8, 2021
Study Record Updates
Last Update Posted (Actual)
July 8, 2021
Last Update Submitted That Met QC Criteria
July 7, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- AL - RNI ORIF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
No IPD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthodontic Retention Procedures
-
Noor Sattar RaheemRecruitingOrthodontic Relapse | Orthodontic Retention ApplianceIraq
-
University of MalayaRecruiting
-
Essraa hassan Hussein MohamedNot yet recruitingOrthodontic Retention Appliance | Clear Orthodontic RetainersEgypt
-
Aydin Adnan Menderes UniversityCompleted
-
Region GävleborgMalmö University; Swedish Dental Associations Scientific Funds; Department of... and other collaboratorsCompletedOrthodontic Anchorage Procedures | Orthodontic Space ClosureSweden
-
University of AthensCompletedOrthodontic Retention ComplianceGreece
-
Piotr FudalejActive, not recruitingOrthodontic Retention
-
Queen Mary University of LondonCompletedRetention | Compliance | Periodontal Health | OrthodonticUnited Kingdom
-
Manal El NamrawyUnknownOrthodontic Anchorage Procedures
-
Alexandria UniversityCompleted
Clinical Trials on Orthodontic retention procedures survey
-
Region Örebro CountyRecruitingStability | Dental MalocclusionSpain, Sweden
-
The University of Hong KongCompletedPeriodontal Diseases | OrthodonticsHong Kong
-
Mayo ClinicColumbia UniversityEnrolling by invitationPeriprosthetic Joint InfectionUnited States
-
Mayo ClinicRecruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
Merve YETİMOĞLUKaradeniz Technical UniversityRecruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)SuspendedVulvar Cancer | Recurrent Ovarian Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Invasive Breast Cancer | Malignant Uterine Neoplasm | Recurrent Breast Carcinoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruitingPregnant WomenChina, Rwanda
-
Vidasym, Inc.CompletedChronic-kidney Disease Stage 5D on Stable HemodialysisUnited States
-
Trellis Bioscience LLCActive, not recruitingStudy to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint InfectionProsthetic Joint Infections of Hip | Prosthetic Joint Infections of KneeUnited States